Clinical Evaluation of Stabilizing Splint (Michigan-type Occlusal Splint) Versus Anterior Repositioning Splint .
Launched by CAIRO UNIVERSITY · Nov 8, 2016
Trial Information
Current as of June 24, 2025
Unknown status
Keywords
ClinConnect Summary
To evaluate the effectiveness of Michigan-type occlusal splint and anterior repositioning splint in patients with temporomandibular joint anterior disc displacement with reduction.
PICO:
Population (P): Patients with symptomatic anterior disc displacement with reduction.
Intervention (I): Michigan splint. Comparator (C): Anterior repositioning splint (ARS) .
Outcome(O):
Primary outcome: Patients' subjective pain experience. Each patient will be asked to rate his or her current and worst pain intensity on numerical rating scale (NRS) of 0-10 with zero being no pain and ten corresponds t...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Adult patient from 15 to 50 years old.
- • 2. Report of pain in preauricular region worsened by functional activities, such as chewing and talking.
- • 3. Presence of disc displacement with reduction and joint clicking
- • 4. positive diagnosis of unilateral or bilateral anterior disc displacement with reduction by means of magnetic resonance imaging (MRI).
- Exclusion Criteria:
- • 1. . .
- • 2. History of TMJ surgery.
- • 3. Individuals with osteoarthritis.
- • 4. Individuals under TMD management.
- • 5. Individuals wearing full or partial dentures.
- • 6. Individuals with major psychological disorders.
- • 7. Nonreducing dislocations of the articular disc
- • 8. Consequences of condyle fractures and/or fracture of another maxillofacial zone.
- • 9. Articular pathologies of systemic nature (e.g., rheumatoid arthritis, arthrosis, psoriasis arthritis).
- • 10. Individuals with a recent history of trauma in the face and/or neck area. Individuals with systemic diseases that can affect TMJ
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Nadia Galal, MD
Study Director
Cairo University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials